CXSB0500073 | 冻干静脉注射用人免疫球蛋白(S/D) | | Lyophilized | Biological Products | Supplementary Application | 2005-06-15 | 兰州生物制品研究所 | Lanzhou Institute of Biological Products Co Ltd | Certificate Issued | 2006-02-10 | view |
CXSB2100005 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2021-01-11 | 新疆德源生物工程有限公司 | Xinjiang Deyuan Biological Engineering Co Ltd | Certificate Issued | 2021-07-13 | view |
CXSL1200036 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(15) | New Drug Application | 2012-06-27 | 新疆德源生物工程有限公司 | Xinjiang Deyuan Biological Engineering Co Ltd | Certificate Issued | 2014-07-24 | view |
CXSL1300123 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(15) | New Drug Application | 2014-01-27 | 河北大安制药有限公司 | Bohui Biopharmaceutical (Hebei) Co Ltd | Certificate Issued | 2015-05-13 | view |
CXSL1400048 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(15) | New Drug Application | 2014-05-29 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | Certificate Issued | 2015-10-20 | view |
CXSL1400052 | 10%静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(7) | New Drug Application | 2014-06-13 | 武汉生物制品研究所有限责任公司 | Wuhan Institute of Biological Products Co Ltd | Certificate Issued | 2015-12-10 | view |
CXSL1700099 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(15) | New Drug Application | 2017-11-03 | 四川远大蜀阳药业股份有限公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2017-11-01 | view |
CXSL1700123 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products(7) | New Drug Application | 2017-12-07 | 贵州泰邦生物制品有限公司 | Guizhou Taibang Biological Products Co Ltd | Certificate Issued | 2018-11-09 | view |
CXSL1900155 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(7) | New Drug Application | 2020-01-20 | 华兰生物工程股份有限公司 | Hualan Biological Engineering Inc | In Review | 2020-01-19 | view |
CXSL1900156 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(7) | New Drug Application | 2020-01-20 | 华兰生物工程股份有限公司 | Hualan Biological Engineering Inc | In Review | 2020-01-19 | view |
CXSL1900157 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(7) | New Drug Application | 2020-01-20 | 华兰生物工程股份有限公司 | Hualan Biological Engineering Inc | In Review | 2020-01-19 | view |
CXSL2101366 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2021-10-14 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
CXSL2200012 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-01-12 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
CXSL2200013 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-01-12 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
CXSL2200229 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2022-05-27 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
CXSL2200230 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2022-05-27 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
CXSL2200603 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-12-16 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
CXSL2200604 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-12-16 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
CXSL2400234 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2024-04-16 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
CXSL2400412 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2024-06-26 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |